XML 42 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segments (Tables)
 6 Months Ended
Jun. 30, 2016
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended June 30,
 
For the six months ended June 30,
(In thousands)
2016
 
2015
 
2016
 
2015
Revenue from services:
 
 
 
 
 
 
 
Pharmaceutical
$
—

 
$
—

 
$
—

 
$
—

Diagnostics
266,012

 
1,848

 
518,534

 
3,857

Corporate
—

 
60

 
—

 
120

 
$
266,012

 
$
1,908

 
$
518,534

 
$
3,977

Product revenues:
 
 
 
 
 
 
 
Pharmaceutical
$
22,807

 
$
22,848

 
$
42,706

 
$
38,334

Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
22,807

 
$
22,848

 
$
42,706

 
$
38,334

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceutical
$
68,281

 
$
17,673

 
$
86,898

 
$
30,202

Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
68,281

 
$
17,673

 
$
86,898

 
$
30,202

Operating income (loss):
 
 
 
 
 
 
 
Pharmaceutical
$
35,345

 
$
(4,660
)
 
$
34,015

 
$
(42,584
)
Diagnostics
10,374

 
(7,098
)
 
8,019

 
(15,575
)
Corporate
(17,453
)
 
(12,905
)
 
(41,286
)
 
(22,882
)
Less: Operating loss attributable to noncontrolling interests
—

 
(746
)
 
—

 
(1,281
)
 
$
28,266

 
$
(25,409
)
 
$
748

 
$
(82,322
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceutical
$
2,987

 
$
2,371

 
$
5,848

 
$
4,138

Diagnostics
21,573

 
1,754

 
40,893

 
3,501

Corporate
20

 
27

 
39

 
46

 
$
24,580

 
$
4,152

 
$
46,780

 
$
7,685

Net income (loss) from investment in investees:
 
 
 
 
 
 
 
Pharmaceutical
$
391

 
$
(804
)
 
$
(4,430
)
 
$
(2,565
)
Diagnostics
(2,379
)
 
—

 
97

 
—

Corporate
—

 
—

 
—

 
—

 
$
(1,988
)
 
$
(804
)
 
$
(4,333
)
 
$
(2,565
)
Revenues:
 
 
 
 
 
 
 
United States
$
266,044

 
$
2,525

 
$
518,482

 
$
5,019

Ireland
71,789

 
19,376

 
93,932

 
31,480

Chile
9,597

 
8,698

 
16,580

 
15,150

Spain
4,324

 
4,920

 
8,347

 
8,857

Israel
4,420

 
5,942

 
9,162

 
10,155

Mexico
926

 
968

 
1,635

 
1,852

 
$
357,100

 
$
42,429

 
$
648,138

 
$
72,513


(In thousands)
June 30,
2016
 
December 31,
2015
Assets:
 
 
 
Pharmaceutical
$
1,283,339

 
$
1,234,752

Diagnostics
1,408,619

 
1,421,034

Corporate
82,063

 
143,402

 
$
2,774,021

 
$
2,799,188

Goodwill:

 

Pharmaceutical
$
253,237

 
$
251,225

Diagnostics
437,823

 
492,123

Corporate
—

 
—

 
$
691,060

 
$
743,348